Chiron Corporation (Nasdaq: CHIR) entered into an amendment to its previously announced merger agreement with Novartis (NYSE: NVS) providing for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE